Metformin Role in Diabetic Patients with Tuberculosis: a Review

Metformin Role in Diabetic Patients with Tuberculosis: a Review

Tuberculosis (TB) epidemic is a global health challenge, and WHO estimated the incidence of the new cases reaching 11.1 million people in 2017. Indonesia is classified as a high TB burden country, with 8% of its population infected by TB and ranks third in the world. Type-2 diabetes mellitus (T2DM)...

Full description

Bibliographic Details
Main Author:	Esravila Ariya Wibisono
Format:	Article
Language:	English
Published:	Mulawarman University 2021-06-01
Series:	Journal of Tropical Pharmacy and Chemistry
Subjects:	metformin tuberculosis type-2 diabetes mellitus
Online Access:	https://jtpc.farmasi.unmul.ac.id/index.php/jtpc/article/view/275

Similar Items

Relationship between metformin use and mortality in tuberculosis patients with diabetes: a nationwide cohort study
by: Eunki Chung, et al.
Published: (2024-03-01)

Metformin as a potential protective therapy against tuberculosis in patients with diabetes mellitus: A retrospective cohort study in a single teaching hospital
by: Chia‐Po Fu, et al.
Published: (2021-09-01)

The cumulative dose-dependent effects of metformin on the development of tuberculosis in patients newly diagnosed with type 2 diabetes mellitus
by: Eunyoung Heo, et al.
Published: (2021-09-01)

The Relationship between Metformin and Cancer in Patients with Type 2 Diabetes
by: Hyun Hee Chung, et al.
Published: (2013-04-01)

Comparison of Vildagliptin-Metformin and Glimepiride-Metformin Treatments in Type 2 Diabetic Patients
by: Hyun Jeong Jeon, et al.
Published: (2011-10-01)

ASSOCIATION OF VITAMIN B12 DEFICIENCY AND METFORMIN USE IN PATIENTS PRESENTING WITH TYPE II DIABETES MELLITUS
by: Karamat Ali, et al.
Published: (2020-10-01)

Metformin is the most recognized first choice drug for patients with type 2 diabetes mellitus
by: A. M. Mkrtumyan
Published: (2018-03-01)

The role of metformin in the treatment of type 2 diabetes and obesity's
by: Vuković Mira H.
Published: (2016-01-01)

Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial
by: Tae Jung Oh, et al.
Published: (2019-06-01)

Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
by: Alexander Sergeevich Ametov, et al.
Published: (2010-09-01)

Severity of gastrointestinal side effects of metformin tablet compared to metformin capsule in type 2 diabetes mellitus patients
by: Mansour Siavash, et al.
Published: (2017-01-01)

Latent tuberculosis infection among patients with type 2 diabetes mellitus
by: Mohammed A Agha, et al.
Published: (2020-01-01)

Clinical Trial: Probiotics in Metformin Intolerant Patients with Type 2 Diabetes (ProGasMet)
by: Katarzyna Nabrdalik, et al.
Published: (2023-12-01)

Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?
by: Dzięgielewska-Gęsiak S, et al.
Published: (2022-11-01)

Effect of metformin monotherapy on serum lipid profile in statin-naïve individuals with newly diagnosed type 2 diabetes mellitus: a cohort study
by: Szu Han Lin, et al.
Published: (2018-04-01)

Protective effects of metformin on pancreatic β-cell ferroptosis in type 2 diabetes in vivo
by: Yue Sun, et al.
Published: (2023-12-01)

Differential effect of metformin and/or glyburide on apelin serum levels in patients with type 2 diabetes mellitus: Concepts and clinical practice
by: Hayder M Al-Kuraishy, et al.
Published: (2018-01-01)

Impact of metformin use among tuberculosis close contacts with diabetes mellitus in a nationwide cohort study
by: Ming-Chia Lee, et al.
Published: (2019-11-01)

Step-by-step Individual Intensification of Therapy for Type 2 Diabetes Mellitus. What is Further Choice after Metformin? (Literature Review)
by: І.V. Pankiv
Published: (2015-03-01)

Repurposing of Metformin for the prevention and treatment of Tuberculosis
by: Navya Vyas, et al.
Published: (2022-11-01)

Comparative evaluation of efficacy and safety of combination of metformin-vidagliptin versus metfromin-glimepiride in most frequently used doses in patients of type 2 diabetes mellitus with inadequately controlled metformin monotherapy-A randomised open label study
by: Shallini Gupta, et al.
Published: (2015-01-01)

Advantages of the use of metformin in patients with impaired uric acid metabolism
by: Maksim S. Eliseev, et al.
Published: (2021-05-01)

Effect of diacerein as an add-on to metformin in patients with type 2 diabetes mellitus and inadequate glycemic control
by: Miriam Méndez-del Villar, et al.
Published: (2017-02-01)

Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
by: Zhang Q, et al.
Published: (2020-12-01)

Comparison of the Efficacy of Glimepiride, Metformin, and Rosiglitazone Monotherapy in Korean Drug-Naïve Type 2 Diabetic Patients: The Practical Evidence of Antidiabetic Monotherapy Study
by: Kun Ho Yoon, et al.
Published: (2011-02-01)

Phenotypic and genetic characteristics of patients with type 2 diabetes with different responses to metformin therapy in Novosibirsk region
by: Irina A. Bondar, et al.
Published: (2016-05-01)

Role of Metformin in Morbidity and Mortality Associated with Urinary Tract Infections in Patients with Type 2 Diabetes
by: Fu-Shun Yen, et al.
Published: (2022-04-01)

Incidence and Survival of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Cirrhosis Who Were Treated with and without Metformin
by: Tangjarusritaratorn T, et al.
Published: (2021-04-01)

The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus
by: Chae Bin Lee, et al.
Published: (2021-03-01)

Proteomic Profiling Identifies Distinct Regulation of Proteins in Obese Diabetic Patients Treated with Metformin
by: Awad Alshahrani, et al.
Published: (2023-09-01)

Metformin-Associated Lactic Acidosis: Predisposing Factors and Outcome
by: Min Ju Kim, et al.
Published: (2015-03-01)

PHARMACOECONOMICAL APPROVAL OF GENOTYPING ELIGIBILITY IN PATIENTS WITH DIABETES MELLITUS TYPE 2 TAKING METFORMIN
by: Y. A. SOROKINA, et al.
Published: (2016-12-01)

Relationship between metformin and frailty syndrome in elderly people with type 2 diabetes
by: Svetlana Igorevna Andreeva
Published: (2015-04-01)

Impact of metformin on the risk and treatment outcomes of tuberculosis in diabetics: a systematic review
by: Xinyu Yu, et al.
Published: (2019-10-01)

Metformin inhibits knee osteoarthritis induced by type 2 diabetes mellitus in rats: S100A8/9 and S100A12 as players and therapeutic targets
by: Wang Xin, et al.
Published: (2024-04-01)

Effect of metformin on the bioavailability of nitric oxide in patients with type 2 diabetes
Published: (2012-03-01)

Cognitive Function in Type 2 Diabetes Mellitus Patients Taking Metformin and Metformin-Sulfonylurea
by: Abu Rachman, et al.
Published: (2022-11-01)

Efficacy and safety of teneligliptin added to metformin in Chinese patients with type 2 diabetes mellitus inadequately controlled with metformin: A phase 3, randomized, double‐blind, placebo‐controlled study
by: Linong Ji, et al.
Published: (2021-04-01)

Multidimensional effects of metformin in patients with type 2 diabetes
by: Lyudmila A. Ruyatkina, et al.
Published: (2017-08-01)

Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment
by: Tatiana Ivanovna Romantsova, et al.
Published: (2013-03-01)